+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07301814

Non-Invasive PET Imaging Targeting CLDN18.2 for Detecting and Evaluating Gastric, Pancreatic, Bile Duct, and Esophageal Cancers

Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-12-24

56

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of integrated PETMR or PETCT imaging to detect Claudin18.2 CLDN18.2 in patients with confirmed or suspected malignant tumors such as gastric cancer, pancreatic cancer, cholangiocarcinoma, and esophageal cancer, as well as in healthy volunteers. The aim is to evaluate the feasibility, accuracy, and clinical value of a CLDN18.2-specific PET imaging probe for non-invasive visualization of these tumors. This research also explores how this imaging might help in selecting patients for CLDN18.2-targeted therapies and guide treatment decisions. The study uses a CLDN18.2-targeted PET imaging agent, such as a 68GaGa-labeled humanized antibody fragment, to perform scans on eligible patients and healthy volunteers. Imaging includes PETMR or PETCT methods to identify tumor lesions, assess their location, extent, and metabolic characteristics, and compare findings with standard histopathology and 18FFDG PET imaging. For healthy volunteers, the study will also analyze how the radiotracer distributes and clears in the body. Participants will undergo imaging scans and provide biological samples such as blood and urine for analysis during the study. Researchers will assess visual and standardized uptake values of lesions and biodistribution over one year. Tumor tissue pathology will be examined, and radiotracer radioactivity in samples will be monitored. The study aims to provide detailed diagnostic information and evaluate the radiotracers safety and behavior in the body throughout the observation period.

CONDITIONS

Brief Title

Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

Research Team

X

Xiaoli Lan, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here